Selective neck dissection for clinically node-positive oral cavity squamous cell carcinoma

Yoo Seob Shin, Yoonwoo Koh, Se Heon Kim, Eun Chang Choi

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

Purpose: The treatment of a clinically node-positive (cN+) neck is important in the management of oral cavity squamous cell carcinoma (OSCC). However, the extent of neck dissection (ND) remains controversial. The purpose of our study was to evaluate whether level IV or V can be excluded in therapeutic ND for cN+ OSCC patients. Materials and Methods: We performed a retrospective chart review of 92 patients who underwent a comprehensive or selective ND as a therapeutic treatment of cN+ OSCC from January 1993 to February 2009. Results: The incidence rate of metastasis to level IV or V was 22% (16 of 72) on the ipsilateral neck. Of 67 cases without clinically suspicious nodes at level IV or V, 11 cases (16%, 11 of 67) had pathologically proven lymphatic metastasis to level IV or V. Only a nodal staging above N2b was significantly relevant with the higher rate of level IV or V lymph node metastasis (p=0.025). In this series, selective ND, combined with proper adjuvant therapy, achieved regional control and survival rates comparable to comprehensive ND in patients under the N stage of cN2a OSCC. Conclusion: In conclusion, level IV and V patients can avoid recurrence under cN2a OSCC.

Original languageEnglish
Pages (from-to)139-144
Number of pages6
JournalYonsei medical journal
Volume54
Issue number1
DOIs
Publication statusPublished - 2013 Jan 1

Fingerprint

Neck Dissection
Mouth
Squamous Cell Carcinoma
Neck
Neoplasm Metastasis
Lymphatic Metastasis
Therapeutics
Survival Rate
Lymph Nodes
Recurrence
Incidence

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Shin, Yoo Seob ; Koh, Yoonwoo ; Kim, Se Heon ; Choi, Eun Chang. / Selective neck dissection for clinically node-positive oral cavity squamous cell carcinoma. In: Yonsei medical journal. 2013 ; Vol. 54, No. 1. pp. 139-144.
@article{611fee72cf834d5da41d43784a8cb040,
title = "Selective neck dissection for clinically node-positive oral cavity squamous cell carcinoma",
abstract = "Purpose: The treatment of a clinically node-positive (cN+) neck is important in the management of oral cavity squamous cell carcinoma (OSCC). However, the extent of neck dissection (ND) remains controversial. The purpose of our study was to evaluate whether level IV or V can be excluded in therapeutic ND for cN+ OSCC patients. Materials and Methods: We performed a retrospective chart review of 92 patients who underwent a comprehensive or selective ND as a therapeutic treatment of cN+ OSCC from January 1993 to February 2009. Results: The incidence rate of metastasis to level IV or V was 22{\%} (16 of 72) on the ipsilateral neck. Of 67 cases without clinically suspicious nodes at level IV or V, 11 cases (16{\%}, 11 of 67) had pathologically proven lymphatic metastasis to level IV or V. Only a nodal staging above N2b was significantly relevant with the higher rate of level IV or V lymph node metastasis (p=0.025). In this series, selective ND, combined with proper adjuvant therapy, achieved regional control and survival rates comparable to comprehensive ND in patients under the N stage of cN2a OSCC. Conclusion: In conclusion, level IV and V patients can avoid recurrence under cN2a OSCC.",
author = "Shin, {Yoo Seob} and Yoonwoo Koh and Kim, {Se Heon} and Choi, {Eun Chang}",
year = "2013",
month = "1",
day = "1",
doi = "10.3349/ymj.2013.54.1.139",
language = "English",
volume = "54",
pages = "139--144",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "1",

}

Selective neck dissection for clinically node-positive oral cavity squamous cell carcinoma. / Shin, Yoo Seob; Koh, Yoonwoo; Kim, Se Heon; Choi, Eun Chang.

In: Yonsei medical journal, Vol. 54, No. 1, 01.01.2013, p. 139-144.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Selective neck dissection for clinically node-positive oral cavity squamous cell carcinoma

AU - Shin, Yoo Seob

AU - Koh, Yoonwoo

AU - Kim, Se Heon

AU - Choi, Eun Chang

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Purpose: The treatment of a clinically node-positive (cN+) neck is important in the management of oral cavity squamous cell carcinoma (OSCC). However, the extent of neck dissection (ND) remains controversial. The purpose of our study was to evaluate whether level IV or V can be excluded in therapeutic ND for cN+ OSCC patients. Materials and Methods: We performed a retrospective chart review of 92 patients who underwent a comprehensive or selective ND as a therapeutic treatment of cN+ OSCC from January 1993 to February 2009. Results: The incidence rate of metastasis to level IV or V was 22% (16 of 72) on the ipsilateral neck. Of 67 cases without clinically suspicious nodes at level IV or V, 11 cases (16%, 11 of 67) had pathologically proven lymphatic metastasis to level IV or V. Only a nodal staging above N2b was significantly relevant with the higher rate of level IV or V lymph node metastasis (p=0.025). In this series, selective ND, combined with proper adjuvant therapy, achieved regional control and survival rates comparable to comprehensive ND in patients under the N stage of cN2a OSCC. Conclusion: In conclusion, level IV and V patients can avoid recurrence under cN2a OSCC.

AB - Purpose: The treatment of a clinically node-positive (cN+) neck is important in the management of oral cavity squamous cell carcinoma (OSCC). However, the extent of neck dissection (ND) remains controversial. The purpose of our study was to evaluate whether level IV or V can be excluded in therapeutic ND for cN+ OSCC patients. Materials and Methods: We performed a retrospective chart review of 92 patients who underwent a comprehensive or selective ND as a therapeutic treatment of cN+ OSCC from January 1993 to February 2009. Results: The incidence rate of metastasis to level IV or V was 22% (16 of 72) on the ipsilateral neck. Of 67 cases without clinically suspicious nodes at level IV or V, 11 cases (16%, 11 of 67) had pathologically proven lymphatic metastasis to level IV or V. Only a nodal staging above N2b was significantly relevant with the higher rate of level IV or V lymph node metastasis (p=0.025). In this series, selective ND, combined with proper adjuvant therapy, achieved regional control and survival rates comparable to comprehensive ND in patients under the N stage of cN2a OSCC. Conclusion: In conclusion, level IV and V patients can avoid recurrence under cN2a OSCC.

UR - http://www.scopus.com/inward/record.url?scp=84871341760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871341760&partnerID=8YFLogxK

U2 - 10.3349/ymj.2013.54.1.139

DO - 10.3349/ymj.2013.54.1.139

M3 - Review article

VL - 54

SP - 139

EP - 144

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 1

ER -